The notices

On November 20, 2026, the Federal Register published two notices that the U.S. International Trade Commission has received section 337 complaints. Both notices were issued on November 17, 2026. Each is a notice of receipt of a complaint and a solicitation of comments on the public interest. Neither notice institutes an investigation.

The notice at 91 Fed. Reg. 75346, FR Doc. 2026-23619, concerns a complaint entitled Certain Mammography Systems with Focal Spot Compensation Technology and Components Thereof, Including X-Ray Tubes, DN 3951. It says the Commission received the complaint and a submission under section 210.8(b) of the Commission's Rules of Practice and Procedure, filed on behalf of Hologic, Inc. on November 16, 2026. The complaint alleges violations of section 337 of the Tariff Act of 1930, 19 U.S.C. 1337, in the importation into the United States, the sale for importation, and the sale within the United States after importation of certain mammography systems with focal spot compensation technology and components thereof, including x-ray tubes. The complaint names as Respondents Siemens Healthineers AG of Germany, Siemens Healthcare GmbH of Germany, and Siemens Medical Solutions USA, Inc. of Malvern, Pennsylvania. Hologic asks the Commission to issue a limited exclusion order and cease and desist orders, and to impose a bond on the Respondents' alleged infringing articles during the 60-day Presidential review period under 19 U.S.C. 1337(j).

The notice at 91 Fed. Reg. 75347, FR Doc. 2026-23627, concerns a complaint entitled Certain Mammography Systems and Components Thereof, DN 3952. It says the Commission received the complaint and a submission under section 210.8(b), filed on behalf of Siemens Medical Solutions USA, Inc. on November 16, 2026. The complaint alleges violations of section 337 of the Tariff Act of 1930, 19 U.S.C. 1337, in the importation into the United States, the sale for importation, and the sale within the United States after importation of certain mammography systems and components thereof. The complaint names as the Respondent Hologic, Inc. of Marlborough, Massachusetts. Siemens Medical Solutions USA, Inc. asks the Commission to issue a limited exclusion order and cease and desist orders, and to impose a bond on respondents' alleged infringing articles during the 60-day Presidential review period under 19 U.S.C. 1337(j).

The district court suits

The companies also sued each other in the District of Delaware. On November 13, 2026, Siemens Medical Solutions USA, Inc. filed Siemens Medical Solutions USA, Inc. v. Hologic, Inc., No. 1:26-cv-01460, a complaint for patent infringement with a jury demand. On November 16, 2026, Hologic, Inc. filed Hologic, Inc. v. Siemens Healthineers AG, No. 1:26-cv-01470, a complaint for patent infringement with a jury demand against Siemens Healthineers AG, Siemens Healthcare GmbH, and Siemens Medical Solutions USA, Inc. Siemens Medical Solutions USA, Inc.'s complaint asserts U.S. Patent 8,284,894 against Hologic mammography systems, including the Envision Mammography Platform. Hologic's complaint asserts U.S. Patents 8,457,282, 8,515,005, 8,767,911, 9,502,148, and 9,895,115 against Siemens MAMMOMAT B.brilliant digital mammography and breast tomosynthesis systems and related configurations, components, X-ray tubes, X-ray tube assemblies, and accessories.

Public interest comments

For each notice, written submissions on the public interest must be filed by close of business, eight calendar days after the notice's publication in the Federal Register. The complainant may file replies no later than three calendar days after the date the written submissions were due. The notices say those deadlines are counted by calendar days, starting with the first calendar day after publication, or after the due date for the written submissions. Submissions and replies are limited to five pages, including attachments. Submissions on DN 3951 should cite Docket No. 3951, and submissions on DN 3952 should cite Docket No. 3952. The Commission invites comment on whether the relief requested in that complaint would affect the public health and welfare in the United States, competitive conditions in the United States economy, the production of like or directly competitive articles in the United States, or United States consumers.

What to watch next

Watch for the public interest submissions and replies, and for the Commission's decision on whether to institute an investigation on either complaint. In the District of Delaware, watch for an answer or a Rule 12 motion in No. 1:26-cv-01460 and in No. 1:26-cv-01470. The case can end at any time, including by settlement or voluntary dismissal.